Balyasny Asset Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-360,599	Closed	-$573K	–	2558
2024 Q1	$573K	Buy	+360,599	New	+$573K	﹤0.01%	1433
2023 Q1	–	Sell	-15,600	Closed	-$78.3K	–	2761
2022 Q4	$78.3K	Buy	+15,600	New	+$78.3K	﹤0.01%	1842